MeSH Review:
Virus Latency
- Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity. Weinberger, L.S., Burnett, J.C., Toettcher, J.E., Arkin, A.P., Schaffer, D.V. Cell (2005)
- Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects. Bryson, Y.J., Dillon, M., Lovett, M., Acuna, G., Taylor, S., Cherry, J.D., Johnson, B.L., Wiesmeier, E., Growdon, W., Creagh-Kirk, T., Keeney, R. N. Engl. J. Med. (1983)
- Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Wong, J.K., Hezareh, M., Günthard, H.F., Havlir, D.V., Ignacio, C.C., Spina, C.A., Richman, D.D. Science (1997)
- Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial. Wade, J.C., Newton, B., McLaren, C., Flournoy, N., Keeney, R.E., Meyers, J.D. Ann. Intern. Med. (1982)
- Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. Schaefer, B.C., Strominger, J.L., Speck, S.H. Proc. Natl. Acad. Sci. U.S.A. (1995)
- Sensory neurons regulate the effector functions of CD8(+) T cells in controlling HSV-1 latency ex vivo. Prabhakaran, K., Sheridan, B.S., Kinchington, P.R., Khanna, K.M., Decman, V., Lathrop, K., Hendricks, R.L. Immunity (2005)
- Modulation of human immunodeficiency virus 1 replication by interferon regulatory factors. Sgarbanti, M., Borsetti, A., Moscufo, N., Bellocchi, M.C., Ridolfi, B., Nappi, F., Marsili, G., Marziali, G., Coccia, E.M., Ensoli, B., Battistini, A. J. Exp. Med. (2002)
- Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism. Zalani, S., Holley-Guthrie, E., Kenney, S. Proc. Natl. Acad. Sci. U.S.A. (1996)
- N-linked oligosaccharides on herpes simplex virus glycoprotein gD are not essential for establishment of viral latency or reactivation in the mouse eye model. Tal-Singer, R., Eisenberg, R.J., Valyi-Nagy, T., Fraser, N.W., Cohen, G.H. Virology (1994)
- Establishment of herpes simplex virus latency in vitro with cycloheximide. Shiraki, K., Rapp, F. J. Gen. Virol. (1986)
- Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replication. Zhang, Q., Hong, Y., Dorsky, D., Holley-Guthrie, E., Zalani, S., Elshiekh, N.A., Kiehl, A., Le, T., Kenney, S. J. Virol. (1996)
- Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Cheung, S.T., Huang, D.P., Hui, A.B., Lo, K.W., Ko, C.W., Tsang, Y.S., Wong, N., Whitney, B.M., Lee, J.C. Int. J. Cancer (1999)
- Photochemical deamination and demethylation of 5-methylcytosine. Privat, E., Sowers, L.C. Chem. Res. Toxicol. (1996)
- Interleukin-10 inhibits initial reverse transcription of human immunodeficiency virus type 1 and mediates a virostatic latent state in primary blood-derived human macrophages in vitro. Montaner, L.J., Griffin, P., Gordon, S. J. Gen. Virol. (1994)
- Epstein-Barr virus gene expression in human breast cancer: protagonist or passenger? Xue, S.A., Lampert, I.A., Haldane, J.S., Bridger, J.E., Griffin, B.E. Br. J. Cancer (2003)
- Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia. Young, L.S., Lau, R., Rowe, M., Niedobitek, G., Packham, G., Shanahan, F., Rowe, D.T., Greenspan, D., Greenspan, J.S., Rickinson, A.B. J. Virol. (1991)
- NF-kappaB inhibits gammaherpesvirus lytic replication. Brown, H.J., Song, M.J., Deng, H., Wu, T.T., Cheng, G., Sun, R. J. Virol. (2003)
- Marked, transient inhibition of expression of the Epstein-Barr virus latent membrane protein gene in Burkitt's lymphoma cell lines by electroporation. Gahn, T.A., Sugden, B. J. Virol. (1993)
- Acylovir in oral and ganglionic herpes simplex virus infections. Park, N.H., Pavan-Langston, D., McLean, S.L. J. Infect. Dis. (1979)
- Murine gammaherpesvirus 68 bcl-2 homologue contributes to latency establishment in vivo. de Lima, B.D., May, J.S., Marques, S., Simas, J.P., Stevenson, P.G. J. Gen. Virol. (2005)
- Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia. A randomized, double-blind, placebo-controlled study. Saral, R., Ambinder, R.F., Burns, W.H., Angelopulos, C.M., Griffin, D.E., Burke, P.J., Lietman, P.S. Ann. Intern. Med. (1983)
- Inhibition of HIV activation in latently infected cells by flavonoid compounds. Critchfield, J.W., Butera, S.T., Folks, T.M. AIDS Res. Hum. Retroviruses (1996)
- Enhanced in vitro reactivation of latent herpes simplex virus from neural and peripheral tissues with hexamethylenebisacetamide. Bernstein, D.I., Kappes, J.C. Arch. Virol. (1988)
- Effect of DNA-binding drugs on early growth response factor-1 and TATA box-binding protein complex formation with the herpes simplex virus latency promoter. Chiang, S.Y., Welch, J.J., Rauscher, F.J., Beerman, T.A. J. Biol. Chem. (1996)
- Interleukin-18 expression induced by Epstein-Barr virus-infected cells. Yao, L., Setsuda, J., Sgadari, C., Cherney, B., Tosato, G. J. Leukoc. Biol. (2001)
- Suppression of endothelin system in Vero cells latently infected with influenza virus B/Lee/40. Hayase, Y., Tobita, K. Arch. Virol. (1999)
- The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections. Heise, M.T., Virgin, H.W. J. Virol. (1995)
- BHRF1, the Epstein-Barr virus (EBV) homologue of the BCL-2 protooncogene, is transcribed in EBV-associated B-cell lymphomas and in reactive lymphocytes. Oudejans, J.J., van den Brule, A.J., Jiwa, N.M., de Bruin, P.C., Ossenkoppele, G.J., van der Valk, P., Walboomers, J.M., Meijer, C.J. Blood (1995)
- Natural history of murine gamma-herpesvirus infection. Nash, A.A., Dutia, B.M., Stewart, J.P., Davison, A.J. Philos. Trans. R. Soc. Lond., B, Biol. Sci. (2001)